Statement of Changes in Beneficial Ownership (4)
June 03 2020 - 5:44PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Timmons Kevin L |
2. Issuer Name and Ticker or Trading Symbol
CyrusOne Inc.
[
CONE
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & Chief Technology Officer |
(Last)
(First)
(Middle)
C/O CYRUSONE INC., 2850 N HARWOOD ST, SUITE 2200 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/1/2020 |
(Street)
DALLAS, TX 75201-2640
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 6/1/2020 | | M | | 5000 | A | $36.99 | 48492 | D | |
Common Stock | 6/1/2020 | | S | | 3886 (1) | D | $73.2978 (2) | 44606 | D | |
Common Stock | 6/1/2020 | | S | | 1114 (1) | D | $73.9738 (3) | 43492 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option | $36.99 | 6/1/2020 | | M | | | 5000 | (4) | 2/1/2026 | Common Stock | 5000.0 | $0 | 19817 | D | |
Explanation of Responses: |
(1) | These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2019. |
(2) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.10 to $73.55, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 of this Form 4. |
(3) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.70 to $74.565, inclusive. |
(4) | The option, representing a right to purchase a total of 28,612 shares, became exercisable in three equal annual installments beginning on February 1, 2017. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Timmons Kevin L C/O CYRUSONE INC. 2850 N HARWOOD ST, SUITE 2200 DALLAS, TX 75201-2640 |
|
| EVP & Chief Technology Officer |
|
Signatures
|
/s/ Robert M. Jackson, Attorney-in-Fact | | 6/3/2020 |
**Signature of Reporting Person | Date |
CyrusOne (NASDAQ:CONE)
Historical Stock Chart
From Aug 2024 to Sep 2024
CyrusOne (NASDAQ:CONE)
Historical Stock Chart
From Sep 2023 to Sep 2024